Skip to main content
. 2022 Apr 28;17(4):e0267117. doi: 10.1371/journal.pone.0267117

Fig 5. Screening of SNX16 and PAPOLG related miRNA (miR-101-3p) and miR-101-3p for oncogenic effects in HCC.

Fig 5

(A) the list of SNX16 related miRNA. (B) the list of PAPOLG related miRNA. (C) Differential expression of miR-101-3p. (D) Differential expression of miR-101-3p in paraneoplastic versus HCC tissues. (E) Analysis of overall survival of miR-101-3p expression in HCC patients. miR-101-3p expression and Grade (F), TNM stage (G), and invasion depth (H) of correlation.